Plasma BCAA changes in Patients with NAFLD are Sex Dependent.

CONTEXT Plasma branched chain amino acid (BCAA) concentrations correlate positively with body mass index (BMI), measures of insulin resistance (IR) and severity of non-alcoholic fatty liver disease (NAFLD). Moreover, plasma BCAA concentrations also differ between the sexes, which display different susceptibilities to cardio-metabolic diseases. OBJECTIVE Assess whether plasma BCAA concentrations associate with NAFLD severity independently of BMI, IR and sex. PATIENTS Patients visiting the obesity clinic of the Antwerp University Hospital were consecutively recruited from 2006 to 2014. DESIGN AND SETTING A cross-sectional study cohort of 112 obese patients (59 women and 53 men) was divided into four groups according to NAFLD severity. Groups were matched for sex, age, BMI, HOMA-IR and HbA1c. MAIN OUTCOME MEASURES Fasting plasma BCAA concentrations were measured by tandem mass spectrometry using the aTRAQ™ method. RESULTS In the study cohort, a modest positive correlation was observed between plasma BCAA concentrations and NAFLD severity, as well as a strong effect of sex on plasma BCAA levels. Subgroup analysis by sex revealed that while plasma BCAA concentrations increased with severity of NAFLD in women, they tended to decrease in men. Additionally, only women displayed significantly increased plasma BCAAs with increasing fibrosis. CONCLUSION Plasma BCAA concentrations display sex-dimorphic changes with increasing severity of NAFLD, independently of BMI, IR and age. Additionally, plasma BCAA are associated with significant fibrosis in women, but not in men. These results highlight the importance of a careful consideration of sex as a major confounding factor in cross-sectional studies of NAFLD.

[1]  O. Cummings,et al.  Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease , 2019, JAMA network open.

[2]  A. Suzuki,et al.  Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps , 2019, Hepatology.

[3]  G. Escobedo,et al.  Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population. , 2019, Annals of hepatology.

[4]  Zhaoping Li,et al.  Targeting BCAA Catabolism to Treat Obesity-Associated Insulin Resistance , 2019, Diabetes.

[5]  C. Lewis,et al.  Sex Hormone–Binding Globulin Levels in Young Men Are Associated With Nonalcoholic Fatty Liver Disease in Midlife , 2019, The American journal of gastroenterology.

[6]  E. White,et al.  Quantitative Analysis of the Whole-Body Metabolic Fate of Branched-Chain Amino Acids. , 2019, Cell metabolism.

[7]  P. Gentileschi,et al.  Molecular Phenomics and Metagenomics of Hepatic Steatosis in Non-Diabetic Obese Women , 2018, Nature Medicine.

[8]  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases , 2018, Clinical liver disease.

[9]  A. Gastaldelli,et al.  Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance , 2018, Hepatology.

[10]  A. Canbay,et al.  The Presence and Severity of Nonalcoholic Steatohepatitis Is Associated with Specific Changes in Circulating Bile Acids. , 2018, Annals of hepatology.

[11]  Rohit Kohli,et al.  The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids , 2018, Hepatology.

[12]  E. Dirinck,et al.  Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects , 2017, The Journal of clinical endocrinology and metabolism.

[13]  A. Lonardo,et al.  NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk , 2017, Advances in Therapy.

[14]  C. Lewis,et al.  Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife , 2017, The American Journal of Gastroenterology.

[15]  X. Mao,et al.  Novel metabolic and physiological functions of branched chain amino acids: a review , 2017, Journal of Animal Science and Biotechnology.

[16]  W. Lau,et al.  Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy , 2016, EBioMedicine.

[17]  K. Sugano,et al.  Evidence-based clinical practice guidelines for liver cirrhosis 2015 , 2016, Journal of Gastroenterology.

[18]  H. Tilg,et al.  EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. , 2016, Journal of hepatology.

[19]  Z. Wang,et al.  Obesity is an independent risk factor for non‐alcoholic fatty liver disease: evidence from a meta‐analysis of 21 cohort studies , 2016, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[20]  B. Staels,et al.  Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease. , 2016, Annual review of physiology.

[21]  D. Sabatini,et al.  Sestrin2 is a leucine sensor for the mTORC1 pathway , 2016, Science.

[22]  Fabian J Theis,et al.  Gender-specific pathway differences in the human serum metabolome , 2015, Metabolomics.

[23]  E. van Marck,et al.  PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis. , 2015, Journal of hepatology.

[24]  N. Araníbar,et al.  Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease , 2014, Amino Acids.

[25]  C. Lynch,et al.  Branched-chain amino acids in metabolic signalling and insulin resistance , 2014, Nature Reviews Endocrinology.

[26]  Zhong-li Wang,et al.  Sex-specific prevalence of fatty liver disease and associated metabolic factors in Wuhan, south central China , 2014, European journal of gastroenterology & hepatology.

[27]  R. Kane,et al.  Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease , 2014, Gastroenterology report.

[28]  F. Boemer,et al.  Evaluation of physiological amino acids profiling by tandem mass spectrometry. , 2013, JIMD reports.

[29]  M. Taskinen,et al.  A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population , 2013, Obesity.

[30]  Pierre Bedossa,et al.  Current histological classification of NAFLD: strength and limitations , 2013, Hepatology International.

[31]  N. Araníbar,et al.  Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease. , 2013, Toxicology and applied pharmacology.

[32]  Svati H Shah,et al.  Differential Metabolic Impact of Gastric Bypass Surgery Versus Dietary Intervention in Obese Diabetic Subjects Despite Identical Weight Loss , 2011, Science Translational Medicine.

[33]  K. Saeian,et al.  Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology. , 2011, Annals of diagnostic pathology.

[34]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[35]  Olga Ilkayeva,et al.  Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. , 2008, Cell metabolism.

[36]  Pengxiang She,et al.  Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. , 2007, American journal of physiology. Endocrinology and metabolism.

[37]  M. Roden,et al.  The Mammalian Target of Rapamycin Pathway Regulates Nutrient-Sensitive Glucose Uptake in Man , 2007, Diabetes.

[38]  G. Thomas,et al.  Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. , 2006, Cell metabolism.

[39]  Masahiko Kato,et al.  Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[40]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[41]  Paul Calès,et al.  Sources of variability in histological scoring of chronic viral hepatitis , 2005, Hepatology.

[42]  G. Marchesini,et al.  Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. , 2003, Gastroenterology.

[43]  J. Levy,et al.  Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program , 1998, Diabetes Care.